Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia

A research review

Mary F. Brunette, Douglas L. Noordsy, Peter F. Buckley, Alan I. Green

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Substance use disorders are a common comorbidity in patients with schizophrenia, and are associated with a variety of negative outcomes. Research assessing pharmacotherapy of substance use disorders in patients with schizophrenia is in its infancy, but preliminary data indicate that, in particular, atypical antipsychotic medications may help patients with co-occurring disorders reduce substance use. Clozapine, despite its potential side effects, shows the most promise. Data related to other medications, which may also be helpful in patients with schizophrenia, are reviewed. Further controlled trials are needed to assess the impact of atypical antipsychotics, mood stabilizers, and other agents on substance abuse in patients with schizophrenia. Until such data are available, clinicians should follow established principles of pharmacotherapy for patients with dual disorders, which include using medications to treat both disorders simultaneously over time in the context of psychosocial treatment for dual disorders.

Original languageEnglish (US)
Pages (from-to)41-55
Number of pages15
JournalJournal of Dual Diagnosis
Volume1
Issue number2
DOIs
StatePublished - Sep 9 2005

Fingerprint

Substance-Related Disorders
Schizophrenia
Research
Antipsychotic Agents
Therapeutics
Drug Therapy
Clozapine
Comorbidity

Keywords

  • Schizophrenia
  • Substance abuse
  • Treatment medications

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia : A research review. / Brunette, Mary F.; Noordsy, Douglas L.; Buckley, Peter F.; Green, Alan I.

In: Journal of Dual Diagnosis, Vol. 1, No. 2, 09.09.2005, p. 41-55.

Research output: Contribution to journalReview article

Brunette, Mary F. ; Noordsy, Douglas L. ; Buckley, Peter F. ; Green, Alan I. / Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia : A research review. In: Journal of Dual Diagnosis. 2005 ; Vol. 1, No. 2. pp. 41-55.
@article{ab6c17dfd2624a9f952fc3fc512a6523,
title = "Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia: A research review",
abstract = "Substance use disorders are a common comorbidity in patients with schizophrenia, and are associated with a variety of negative outcomes. Research assessing pharmacotherapy of substance use disorders in patients with schizophrenia is in its infancy, but preliminary data indicate that, in particular, atypical antipsychotic medications may help patients with co-occurring disorders reduce substance use. Clozapine, despite its potential side effects, shows the most promise. Data related to other medications, which may also be helpful in patients with schizophrenia, are reviewed. Further controlled trials are needed to assess the impact of atypical antipsychotics, mood stabilizers, and other agents on substance abuse in patients with schizophrenia. Until such data are available, clinicians should follow established principles of pharmacotherapy for patients with dual disorders, which include using medications to treat both disorders simultaneously over time in the context of psychosocial treatment for dual disorders.",
keywords = "Schizophrenia, Substance abuse, Treatment medications",
author = "Brunette, {Mary F.} and Noordsy, {Douglas L.} and Buckley, {Peter F.} and Green, {Alan I.}",
year = "2005",
month = "9",
day = "9",
doi = "10.1300/J374v01n02_04",
language = "English (US)",
volume = "1",
pages = "41--55",
journal = "Journal of Dual Diagnosis",
issn = "1550-4263",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia

T2 - A research review

AU - Brunette, Mary F.

AU - Noordsy, Douglas L.

AU - Buckley, Peter F.

AU - Green, Alan I.

PY - 2005/9/9

Y1 - 2005/9/9

N2 - Substance use disorders are a common comorbidity in patients with schizophrenia, and are associated with a variety of negative outcomes. Research assessing pharmacotherapy of substance use disorders in patients with schizophrenia is in its infancy, but preliminary data indicate that, in particular, atypical antipsychotic medications may help patients with co-occurring disorders reduce substance use. Clozapine, despite its potential side effects, shows the most promise. Data related to other medications, which may also be helpful in patients with schizophrenia, are reviewed. Further controlled trials are needed to assess the impact of atypical antipsychotics, mood stabilizers, and other agents on substance abuse in patients with schizophrenia. Until such data are available, clinicians should follow established principles of pharmacotherapy for patients with dual disorders, which include using medications to treat both disorders simultaneously over time in the context of psychosocial treatment for dual disorders.

AB - Substance use disorders are a common comorbidity in patients with schizophrenia, and are associated with a variety of negative outcomes. Research assessing pharmacotherapy of substance use disorders in patients with schizophrenia is in its infancy, but preliminary data indicate that, in particular, atypical antipsychotic medications may help patients with co-occurring disorders reduce substance use. Clozapine, despite its potential side effects, shows the most promise. Data related to other medications, which may also be helpful in patients with schizophrenia, are reviewed. Further controlled trials are needed to assess the impact of atypical antipsychotics, mood stabilizers, and other agents on substance abuse in patients with schizophrenia. Until such data are available, clinicians should follow established principles of pharmacotherapy for patients with dual disorders, which include using medications to treat both disorders simultaneously over time in the context of psychosocial treatment for dual disorders.

KW - Schizophrenia

KW - Substance abuse

KW - Treatment medications

UR - http://www.scopus.com/inward/record.url?scp=22144474213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144474213&partnerID=8YFLogxK

U2 - 10.1300/J374v01n02_04

DO - 10.1300/J374v01n02_04

M3 - Review article

VL - 1

SP - 41

EP - 55

JO - Journal of Dual Diagnosis

JF - Journal of Dual Diagnosis

SN - 1550-4263

IS - 2

ER -